IONTAS Signs Collaboration Agreement With LG Chem, Ltd.

IONTAS Limited recently announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd. for the discovery of therapeutic antibodies targeting undisclosed targets for use in the treatment of cancers. Under the agreement, IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by LG Chem, Ltd. and to further prove the biological activity of the antibodies.

 Dr. Neil Butt, CBO of IONTAS, said “This new agreement marks IONTAS’ expansion into the Asian market, and we are delighted to have been selected by LG Chem, Ltd., after a rigorous diligence process. The application of our proprietary technologies will assist LG Chem, Ltd. in expanding its current therapeutic pipeline by generating leads against pre-defined specifications agreed at the project outset.”

 Dr. Myung Jin Kim, Executive Vice President/R&D Leader, Life Sciences R&D of LG Chem, Ltd., added “IONTAS was selected because of its robust track record and technical know-how. We feel confident this collaboration will result in a strong panel of therapeutic leads which will help develop our oncology pipeline.”

 IONTAS is a biotechnology company focused on antibody discovery and cutting-edge technology development. IONTAS offers services for antibody discovery using Phage Display Technology; and the supply of bespoke phage display libraries. In addition, IONTAS offers proprietary antibody discovery platforms including Mammalian Display where full length antibodies are expressed in the context of a mammalian cell thereby allowing selection based on function, stability, expression and developability; IONTAS have also developed a novel “KnotBody” format which facilitates the targeting of antibodies to ion channels, GPCRs and proteases. For more information, visit www.iontas.co.uk.  

Having continued to grow over 7 decades since founded in 1947, LG Chem is leading the chemical industry in Korea. The company has built the global network for production, sales and R&D not only in Korea but also in main bases across the world and has provided globally competitive products including ABS, polarisers and EV battery cells, raising its global position as a material supplier.

The company has strengthened market dominance starting from the Basic Materials & Chemicals business to Energy Solution, IT and Electronic Materials and has expanded its business into Life Science area, building a future-oriented business portfolio. In the long term, the company will build the foundation for sustainable growth by selecting and concentrating on the ‘energy’, ‘water’ and ‘bio’ businesses as the new growth engines.

LG Chem is committed to becoming a global company that realises the vision of “growing with customers by providing innovative materials and solutions” and provides new values to customers. For more information, visit www.lgchem.com.